"South Shore Neurologic Associates, PC is a comprehensive Neurologic care facility which is dedicated to alleviating the symptoms of neurological illness, neurological injury and chronic pain through excellence in patient care, advocacy, service, education and research. We have been providing neurologic care for people living in Suffolk County, Long Island since 1980. We have expanded our practice over the years to set standards in neurologic care on Long Island; through research and innovative treatments while providing comprehensive and personal patient care at our offices in Islip, Patchogue, and Riverhead as well as affiliated hospitals."

During the past decade, South Shore Neurologic Associates P.C. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Shore Neurologic Associates P.C." #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Jazz Pharmaceuticals" with 2 trials sponsored and "CENTOGENE GmbH Rostock" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Shore Neurologic Associates P.C." #1 collaborator was "Bayer" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "South Shore Neurologic Associates" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "South Shore Neurologic Associates P.C." are "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (4 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials) and "Amyotrophic Lateral Sclerosis" (1 trials). Many other conditions were trialed in "South Shore Neurologic Associates P.C." in a lesser frequency.

Most popular intervention types in "South Shore Neurologic Associates P.C." are "Drug" (11 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Placebo" (4 trials), "Ankle-Foot Orthosis (AFO)" (1 trials), "Crenezumab" (1 trials) and "Donanemab" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Shore Neurologic Associates P.C." are 15 trials for "All" genders.

Currently, there are NaN active trials in "South Shore Neurologic Associates P.C.". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in South Shore Neurologic Associates P.C., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in South Shore Neurologic Associates P.C., 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

South Shore Neurologic Associates P.C. has several departments that took part in Clinical trials: "Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates, P.C." - 2 trials